Financial Statements — NBP
Balance Sheet
(in billions USD)| Metric | Q3
2025 | Q2
2025 | Q2
2022 |
|---|
| Cash & Equivalents | 0.23 | 0.17 | 3.71 |
| Short-term Investments | 0.00 | 0.00 | 0.21 |
| Accounts Receivable | -- | -- | 0.00 |
| Inventory | -- | -- | 0.03 |
| Total Current Assets | 0.23 | 0.17 | 4.31 |
| Property, Plant & Equipment | 0.00 | 0.00 | 0.06 |
| Goodwill | -- | -- | 0.02 |
| Intangible Assets | -- | -- | 0.12 |
| Total Non-current Assets* | 0.04 | 0.04 | 0.68 |
| Total Assets | 0.28 | 0.21 | 4.99 |
| Accounts Payable | 0.02 | 0.01 | 0.55 |
| Total Current Liabilities | 0.02 | 0.01 | 0.59 |
| Total Non-current Liabilities* | 0.00 | 0.00 | 0.39 |
| Total Liabilities | 0.02 | 0.01 | 0.98 |
| Retained Earnings | (1.30) | (1.29) | (5.40) |
| Total Stockholder Equity | 0.26 | 0.20 | 4.02 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q3
2025 | Q2
2025 | Q2
2022 |
|---|
| Total Revenue | -- | -- | 51.86 |
| Cost of Revenue | -- | -- | 27.24 |
| Gross Profit | -- | -- | 24.62 |
| Research & Development | 7.25 | 4.07 | 452.62 |
| Selling, General & Admin | 14.12 | 8.31 | 392.46 |
| Total Operating Expenses | 21.37 | 12.38 | -- |
| Operating Income | (21.37) | (12.38) | -- |
| Pretax Income | (15.48) | (8.65) | (1,046.86) |
| Tax Provision | 0.00 | 0.00 | (3.12) |
| Net Income | (15.48) | (8.65) | (156.29) |
| Basic EPS | (0.08) | (0.05) | (5.54) |
| Diluted EPS | (0.08) | (0.05) | (5.54) |
Cash Flow Statement
(in millions USD)| Metric | Q3
2025 | Q2
2025 | Q2
2022 |
|---|
| Operating Cash Flow | (6.00) | (7.84) | (85.27) |
| Capital Expenditures | 0.01 | 0.01 | 18.88 |
| Free Cash Flow* | (6.01) | (7.85) | (104.15) |
| Investing Cash Flow | -- | -- | 499.34 |
| Financing Cash Flow | -- | -- | 35.38 |
* Derived from reported values
